From podcasts to traditional TV, a diversified media strategy boosts impact and reach in today’s marketing landscape.
It’s time, maybe past time, to scale digital transformation globally…but how? How can we make it more efficient to implement new commercial tools like AI? The key is to build flexibility into the global commercial model so companies can leverage economies of scale while incorporating learnings across markets.
Fishawack Health (FH) has added industry creative leader Marcia Goddard as the group’s new chief creative officer, and Scottie Lee has come aboard as chief delivery officer for the U.S. marketing group.
CAR T therapies have revolutionized oncology patient care. But to ensure the often lifesaving benefits of these therapies reach the right patients, life sciences companies must navigate complex decision-making and treatment processes to maximize uptake.
Under the guise of lowering drug prices and curtailing corporate greed, we’re seeing a concerted assault on accelerated approval that insisting drugs whose efficacy is questioned by the FDA be pulled from the market.
Ogilvy Health announced industry veteran Courtney Murphy has been appointed to the position of Global People Director, a newly created role that now rounds out the agency’s powerhouse leadership team. Courtney will serve both as a valued part of the Ogilvy Health Executive Leadership Team and as a board member on Ogilvy’s Global People Team.
Greater Than One, a full-experience marketing agency focused on healthcare, announced that Bindhu Gopalan was appointed Chief Client Officer. She is responsible for overseeing all client engagements at Greater Than One, with a focus on building better healthcare experiences through the agency’s Capability Convergence model.
Diversity in all clinical research—including rare disease research—is currently under scrutiny, partly because of disparities experienced with COVID-19. Rightly so, as data show that 86 percent of genomics studies to date have involved people of European ancestry, which has limited the potential benefits of genomic research for many populations. Rebecca Sutphen, Co-Founder and Chief Medical Officer of InformedDNA, and Board-Certified Genetic Counselor Karmen Trzupek analyze strategies to increase diversity in rare genetic disease trials.
Pharmacovigilance, the industry term for drug safety, was unfamiliar to most of the general public before March 2020. But as the coronavirus pandemic unfolded, its rapid spread thrust drug safety into the spotlight. The public is more aware of drug safety and health regulators’ role than ever — and as the demand for pharmacovigilance information rises, the industry has had to find ways to keep up — according to Beena Wood, VP of safety at ArisGlobal.
If you flip through history, you’ll realize that our fundamental healthcare needs haven’t changed since the year 1885. We still seek rest when we’re ill, feel pain when we overexert ourselves, and need guidance from experts on our health and wellness. But the tools we have to meet these perennial needs have shifted dramatically since the 19th century, and especially over the past decade, wherein technology has advanced faster than even the greatest Sci-Fi film producers imagined, according to Greater Than One Chief Technology Officer Ken Winell.
